← All trials
NCT01567306
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2011
- Primary completion
- Apr 1, 2013
- Completion date
- Apr 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 151
- Arms / groups
- 6 / —
- Source
- AACT · pre-existing
Sponsors
- Roxall MedizinLead sponsor
- Hospital Ntra. Sra. del PradoOverall official - principal investigator
- Instituto CUF PortoOverall official - principal investigator
- Hospital da Universidade de CoimbraOverall official - principal investigator
- Centro Hospitalar de Vila Nova de Gaia/EspinhoOverall official - principal investigator
- Universidad Complutense de MadridOverall official - principal investigator
- Universidad Autonoma de MadridOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.